Results 141 to 145 of about 337 (145)

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma Open Access

Neuro-Oncology Advances
David A Reardon, Randy L Jensen, Howard Colman   +2 more
exaly  

35 Clinicopathologic Characteristics of Pexidartinib- Treated Tenosynovial Giant Cell Tumor

Laboratory Investigation
Dana Hariri, Gregory Cote, Yin (Rex) Hung, Ivan Chebib, Gunnlaugur Nielsen   +4 more
openaire   +1 more source

PEXIDARTINIB HYDROCHLORIDE CRYSTAL FORMS, PREPARATION METHOD THEREFOR AND USE THEREOF

2020
CHEN MINHUA, ZHANG YANFENG, ZOU PO, ZHANG XIAOYU   +3 more
openaire   +1 more source

Patient-reported continued benefits of pexidartinib for tenosynovial giant cell tumor based on a real-world study in the United States Open Access

Oncologist
William D Tap, Dong Dai
exaly  

Pexidartinib impairs liver mitochondrial functions causing cell death in primary human hepatocytes at clinically relevant concentrations

Biochemical and Biophysical Research Communications
William Mattes, Li Pang, Katy Papineau
exaly